NASDAQ · BTMD
Biote Corp.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for BTMD: Nov 04, 2026
Biote Corp. Class A Common Stock is expected to report earnings on 11/04/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.05. The reported EPS for the same quarter last year was $0.22.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.05 | $-0.01 | $-0.09 | 2 |
| Dec 2026 | $-0.03 | $0.01 | $-0.07 | 2 |
| Mar 2027 | $0.04 | $0.04 | $0.04 | 1 |
| Jun 2027 | $0.07 | $0.07 | $0.07 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · Zacks · MarketBeat · RTTNews- The Motley Fool · Aug 12, 7:03 PM EDTBiote (BTMD) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 5, 8:35 PM EDTbiote Corp. (BTMD) Reports Break-Even Earnings for Q2biote Corp. (BTMD) delivered earnings and revenue surprises of -100.00% and -5.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- MarketBeat · Aug 5, 7:04 PM EDTbiote Q2 Earnings Call Highlightsbiote (NASDAQ:BTMD) reported lower second-quarter revenue and a net loss as a voluntary recall of certain hormone pellets supplied by Asteria Health disrupted procedure volumes, while management said supply conditions have since normalized and should support sequential improvemen
- RTTNews · Jun 1, 8:32 AM EDTBiote Appoints Komal Bajaj As CMO(RTTNews) – Biote Corp. (BTMD), a medical practice-building company, on Monday announced the appointment of Komal Bajaj as Chief Medical Officer, effective June 1.
- The Motley Fool · May 6, 7:05 PM EDTBiote (BTMD) Q1 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · May 6, 6:30 PM EDTbiote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimatesbiote Corp. (BTMD) delivered earnings and revenue surprises of -33.33% and -2.71%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Apr 29, 7:45 AM EDTGE HealthCare Technologies (GEHC) Lags Q1 Earnings EstimatesGE HealthCare (GEHC) delivered earnings and revenue surprises of -7.04% and +1.52%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- The Motley Fool · Mar 11, 6:12 PM EDTbiote (BTMD) Q4 2025 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Mar 11, 5:45 PM EDTbiote Corp. (BTMD) Q4 Earnings and Revenues Top Estimatesbiote Corp. (BTMD) delivered earnings and revenue surprises of +20.00% and +1.47%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Feb 25, 8:05 PM ESTUniversal Health Services (UHS) Lags Q4 Earnings EstimatesUniversal Health Services (UHS) delivered earnings and revenue surprises of -0.63% and +0.05%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Feb 10, 8:45 AM ESTOrganiGram (OGI) Reports Q1 Loss, Lags Revenue EstimatesOrganiGram (OGI) delivered earnings and revenue surprises of -100.00% and -14.83%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
- The Motley Fool · Nov 6, 9:50 AM ESTbiote (BTMD) Q3 2025 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Biote Corp. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.